SELLAS Life Sciences Group Inc (NASDAQ: SLS) on Friday, soared 15.38% from the previous trading day, before settling in for the closing price of $3.77. Within the past 52 weeks, SLS’s price has moved between $0.85 and $3.99.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 45.94%. The company achieved an average annual earnings per share of 48.00%. With a float of $141.07 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of SELLAS Life Sciences Group Inc is 0.97%, while institutional ownership is 23.22%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.08 earnings per share (EPS) for the period topping the consensus outlook (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 48.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.75% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
SELLAS Life Sciences Group Inc (SLS) is currently performing well based on its current performance indicators. A quick ratio of 8.28 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.06 in the next quarter and is forecasted to reach -0.32 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
As of the previous 9 days, the stock’s Stochastic %D was 87.75%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 90.52%, which indicates a significant increase from 88.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.36 in the past 14 days, which was higher than the 0.16 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.99, while its 200-day Moving Average is $1.74. Nevertheless, the first resistance level for the watch stands at $4.69 in the near term. At $5.02, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.39. If the price goes on to break the first support level at $3.99, it is likely to go to the next support level at $3.62. Now, if the price goes above the second support level, the third support stands at $3.29.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
Market capitalization of the company is 619.62 million based on 142,442K outstanding shares. Right now, sales total 0 K and income totals -30,880 K. The company made 0 K in profit during its latest quarter, and -6,790 K in sales during its previous quarter.
